Navigation Links
Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel
Date:10/31/2012

nts that involve risks and uncertainties. When used in this release, words such as "anticipates", "believes", "could", "estimates", "expects", "may", "plans", "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in the conduct of clinical trials and other product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; continuation of the GEHC agreement; and the risk factors reported from time to time in the Company's SEC reports. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

About KCSA Strategic Communications
KCSA is a fully-integrated communications agency specializing in public relations, investor relations and marketing with expertise in financial and professional services, technology, healthcare, media, energy and public services companies. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm's clients are its best references. For more information, please visit www.kcsa.com.

Inv
'/>"/>

SOURCE KCSA Strategic Communications
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
2. ViaCyte Receives $10.1 Million Strategic Partnership Award from CIRM to Continue Development of Diabetes Therapy
3. PPCE Announces Strategic Partnership With ECLINSO AG
4. Sage Products Joins APIC Strategic Partner Program
5. CMC Biologics Establishes Commercial Presence in Japan through Strategic Agreement with Innomedica
6. Strategic Agreement Launches Novel Drug Development Model
7. Frost & Sullivan Lauds U-Systems for Its Unique Technology and Strategic Excellence Paving the Way for Robust Growth
8. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
9. Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative
10. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
11. Frost & Sullivan Recognizes Rosetta Genomics for Its Strategic Excellence and Strong Contribution to Next-Generation Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... August 29, 2014 According ... Product & Services (Equipment, Reagent, Primer, Probe, Custom ... PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) - ... global Oligonucleotide Synthesis Market is expected to reach ... 2014, growing at a CAGR of 9.8% from ...
(Date:8/29/2014)... 2014  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... intends to release its financial results for the fiscal ... after market trading ends on Tuesday, September 9, 2014. ... for 4:30 p.m. U.S. EDT on Tuesday, September 9, ... review the Company,s financial results, commercial partnerships, and future ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2
... certain mutations enable specific cells in the,retina to ... suggests deliberate,genetic manipulations might coax an injured brain ... Investigators at St.,Jude Children,s Research Hospital have ... cancer retinoblastoma, disproving a long-standing principle of,nerve growth ...
... Oct. 18 CEL-SCI CORPORATION,(Amex: CVM ) ... is a featured presenter at the International Society ... Mr. Kersten will present on the "New Realities ... p.m. (Eastern Daylight,Time). In April 2007, CEL-SCI ...
Cached Medicine Technology:St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 2St. Jude Identifies the Specific Cell That Causes Eye Cancer, Disproving Long-Held Theory 3CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase 2
(Date:8/29/2014)... Prostate cancer patients lacking knowledge about the disease have ... worse quality of care and long-term results, new research ... median age of 63. All were newly diagnosed with ... was associated with greater difficulty deciding which treatment to ... effective, the study found. "For prostate cancer, there ...
(Date:8/29/2014)... University School of Medicine have identified one way the ... insight that could lead to new therapies, in ... Host & Microbe . , In work performed at ... the researchers developed a detailed map of how a ... that takes signaling molecules in and out of the ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 After ... from Harrisburg, Pa., had to have breast reconstruction. She ... be sub-par, so she decided that there needed to ... better look for a woman or man who needs ... as well as promotes confidence and peace of mind. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Evolutions Medical ... Barbara in the Santa Barbara News-Press Readers’ Choice 2014 ... the Readers’ Choice poll as Best Medical Spa. The ... reads the following about Evolutions Medical Spa recognition: , ... it is recognized as a top-notch, cutting-edge medical spa ...
(Date:8/29/2014)... 2014 RBS Reputation Management has brought a ... The service is to help those individuals and organizations that ... Scam Book. The service would push down the ranking of ... complaints fully invisible on Google. , RBS Reputation Management ... being asked how company can provide guarantee of results with ...
Breaking Medicine News(10 mins):Health News:Faced With Prostate Cancer, It Helps to Know the Enemy 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:RBS Reputation Management Announces a New Online Reputation Management Service 2
... conducted by the University of Texas, and the ... on thinking, memory and other important tasks. ... that chewing gum// targeted memory," Andrew Scholey of the ... words and performed better in tests on working memory." ...
... An innovative way to predict risk of surgery. Lens ... predict when complications are developing after coronary bypass surgery. ... tend to re-block, risking heart attack and requiring further ... could be detected at an early stage, it's possible ...
... smallpox, which kills about 30% of its victims and leaves ... of exposure can protect against illness. A French drug company ... smallpox vaccine and the United States said it would accept ... disease. // ,The UnitedStates has been working to gather ...
... tamoxifen does not damage the brains of elderly ... such treatment, recent study has revealed. According to ... brain to oestrogen, which has been linked with ... researchers used proton magnetic resonance spectroscopy to determine ...
... Plavix (clopidogrel bisulfate) received US Food and Drug Administration ... acute coronary syndrome are at high risk for heart ... disease-related chest pain. About 1.1 to 1.4 million Americans ... was first approved in 1997 for patients with a ...
... Americans are opting for dental implants to replace problem teeth. ... //the traditional solution to the problem is to go for ... inserted into the mouth. But implants teeth inserted into the ... according to the American Dental Association's latest survey. ...
Cached Medicine News:
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The upper body blanket covers the upper torso, arms, neck, and head of the patient....
The Electri-Cool® II is the premier choice when it comes to localized cold therapy systems. system offers the widest variety of application-specific pads and wraps, for your convenience....
Complete Cataract Competence , OPMI VISU 140 is compact, good and economical. It's everything a cataract specialist needs today....
Medicine Products: